Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ENOV

Enovis Corp

Nov 10 • 04:00PM ET

30.26

+2.20 7.84 %

Healthcare • Medical Devices • USA • NYSE

Peers: ZBH SNN SYK JNJ BSX MDT EW ISRG COO BDX

| Held by: IJR VTI VB IWM VBR VXF IJS SPSM IWN DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-24.21	Insider Own	2.18%	Shs Outstand	57.19M	Perf Week	-3.57%
Market Cap	1.73B	Forward P/E	8.77	EPS next Y	3.45	Insider Trans	1.81%	Shs Float	55.94M	Perf Month	1.92%
Enterprise Value	3.14B	PEG	-	EPS next Q	0.81	Inst Own	116.49%	Short Float	12.82%	Perf Quarter	5.25%
Income	-1.37B	P/S	0.77	EPS this Y	12.21%	Inst Trans	1.47%	Short Ratio	8.13	Perf Half Y	-17.25%
Sales	2.23B	P/B	0.86	EPS next Y	8.32%	ROA	-27.39%	Short Interest	7.17M	Perf YTD	-31.04%
Book/sh	35.33	P/C	51.47	EPS next 5Y	11.09%	ROE	-51.11%	52W High	49.75 -39.18%	Perf Year	-35.48%
Cash/sh	0.59	P/FCF	76.00	EPS past 3/5Y	- -4.65%	ROIC	-40.00%	52W Low	25.47 18.83%	Perf 3Y	-40.78%
Dividend Est.	-	EV/EBITDA	11.17	Sales past 3/5Y	13.90% -8.73%	Gross Margin	51.54%	Volatility	6.54% 4.27%	Perf 5Y	-39.75%
Dividend TTM	-	EV/Sales	1.41	EPS Y/Y TTM	-1016.39%	Oper. Margin	-0.48%	ATR (14)	1.40	Perf 10Y	-37.54%
Dividend Ex-Date	-	Quick Ratio	1.16	Sales Y/Y TTM	11.57%	Profit Margin	-61.22%	RSI (14)	45.98	Recom	1.30
Dividend Gr. 3/5Y	- -	Current Ratio	2.22	EPS Q/Q	-1664.17%	SMA20	-3.69%	Beta	1.30	Target Price	48.11
Payout	-	Debt/Eq	0.71	Sales Q/Q	8.65%	SMA50	-3.37%	Rel Volume	1.34	Prev Close	28.06
Employees	7367	LT Debt/Eq	0.69	Earnings	Nov 06 BMO	SMA200	-10.43%	Avg Volume	882.12K	Price	30.26
IPO	May 08, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.56% 1.91%	Trades		Volume	1,179,371	Change	7.84%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-24	Initiated	JMP Securities	Mkt Outperform	$62
Jun-13-24	Initiated	JP Morgan	Neutral	$53
Feb-13-24	Initiated	Stephens	Overweight	$72
Jan-22-24	Initiated	UBS	Buy	$75
Jan-03-24	Initiated	William Blair	Outperform
Dec-15-23	Reiterated	Needham	Buy	$62 → $70
Oct-20-23	Initiated	ROTH MKM	Buy	$75
Jun-26-23	Initiated	Needham	Buy	$70
May-12-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$55 → $67
Oct-12-22	Initiated	Jefferies	Buy	$60
Oct-11-22	Initiated	Goldman	Buy	$57
Sep-12-22	Initiated	Evercore ISI	Outperform	$68
Sep-12-22	Initiated	Canaccord Genuity	Buy	$67
Jun-28-22	Initiated	Argus	Hold
Jun-27-22	Resumed	Loop Capital	Buy	$68
Jun-16-22	Initiated	Wells Fargo	Equal Weight	$61

Show Previous Ratings

Nov-09-25 11:45PM	3 Healthcare Stocks We Approach with Caution (StockStory)
Nov-07-25 09:55AM	ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds (StockStory)
Nov-06-25 08:53AM	Enovis's (NYSE:ENOV) Q3 Sales Top Estimates (StockStory) -9.75%
07:15AM	Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:14AM	Enovis: Q3 Earnings Snapshot (Associated Press Finance)
06:01AM	Loading…
06:01AM	Enovis Announces Third Quarter 2025 Results (GlobeNewswire)
Nov-04-25 10:18PM	Enovis (ENOV) Q3 Earnings: What To Expect (StockStory)
Oct-24-25 04:11PM	Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences (GlobeNewswire)
Oct-14-25 01:06PM	Why Enovis (ENOV) Stock Is Trading Up Today (StockStory)
Oct-08-25 01:45PM	Enovis (ENOV) Stock Trades Up, Here Is Why (StockStory)
08:15AM	Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million (GlobeNewswire)
Sep-08-25 04:05PM	Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference (GlobeNewswire)
Sep-03-25 09:55AM	Wall Street Analysts Believe Enovis (ENOV) Could Rally 69.91%: Here's is How to Trade (Zacks)
Aug-27-25 12:00AM	3 Reasons to Sell ENOV and 1 Stock to Buy Instead (StockStory)
Aug-26-25 11:35PM	Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q2 (StockStory)
09:55AM	Loading…
Aug-18-25 09:55AM	Does Enovis (ENOV) Have the Potential to Rally 77.33% as Wall Street Analysts Expect? (Zacks)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From Enovis's Q2 Earnings Call (StockStory)
Aug-13-25 12:08PM	UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating (Insider Monkey)
Aug-12-25 03:24AM	ENOV Q2 Deep Dive: New CEO Prioritizes Organic Growth, Margin Expansion, and Product Pipeline (StockStory)
Aug-08-25 09:00AM	Enovis to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-25 02:06PM	Enovis's (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3% (StockStory) +10.71%
07:20AM	Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:15AM	Enovis: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Enovis Announces Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 11:04PM	Enovis Earnings: What To Look For From ENOV (StockStory)
Jul-28-25 12:04AM	3 Reasons to Sell ENOV and 1 Stock to Buy Instead (StockStory)
Jul-21-25 01:16PM	Enovis (ENOV) Stock Trades Up, Here Is Why (StockStory)
Jul-18-25 03:10PM	Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know (StockStory) -14.81%
Jul-16-25 09:39AM	Evercore ISI Maintains a Buy on Enovis Corporation (ENOV) With a $46 PT (Insider Monkey)
Jul-08-25 04:05PM	Enovis to Host Second Quarter 2025 Results Conference Call on August 7th (GlobeNewswire) +5.21%
05:38AM	Loading…
Jun-27-25 05:38AM	5 Insightful Analyst Questions From Enovis's Q1 Earnings Call (StockStory)
Jun-24-25 05:42PM	Jefferies Maintains a Buy on Enovis (ENOV), Sets a $60 PT (Insider Monkey) +6.68%
Jun-06-25 04:05PM	Enovis to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-15-25 11:31PM	Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) (StockStory)
May-09-25 03:16AM	Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges (GuruFocus.com)
May-08-25 07:30AM	Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates (Zacks)
06:29AM	Enovis: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Enovis Announces First Quarter 2025 Results (GlobeNewswire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
11:15AM	Enovis Corporation Q1 2025 Earnings Preview (Seeking Alpha)
May-02-25 12:34AM	3 Dawdling Stocks in Hot Water (StockStory)
Apr-29-25 09:02AM	1 Unprofitable Stock with Competitive Advantages and 2 to Question (StockStory)
Apr-22-25 09:06AM	Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock? (Zacks)
Apr-18-25 05:16AM	Reasons to Sell ENOV and 1 Stock to Buy Instead (StockStory)
Apr-17-25 07:00AM	Enovis to Host First Quarter 2025 Results Conference Call on May 8th (GlobeNewswire)
Apr-07-25 04:33AM	Enovis appoints Damien McDonald as CEO (MedTech Dive)
Apr-02-25 06:30AM	Enovis Announces Appointment of Damien McDonald as Chief Executive Officer (GlobeNewswire)
Mar-31-25 09:02AM	2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down (StockStory)
Mar-27-25 10:35PM	Royce Small-Cap Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 08:00AM	Enovis to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 (GlobeNewswire)
Mar-18-25 09:02AM	3 Stocks Under $50 in the Doghouse (StockStory)
Mar-05-25 04:05PM	Enovis to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-27-25 02:09AM	Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook (GuruFocus.com)
01:11AM	Q4 2024 Enovis Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-26-25 07:15AM	Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:43AM	Enovis (NYSE:ENOV) Exceeds Q4 Expectations (StockStory)
06:21AM	Enovis: Q4 Earnings Snapshot (Associated Press Finance)
06:01AM	Enovis Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
06:00AM	Enovis Announces Planned CEO Succession Process (GlobeNewswire)
Feb-25-25 08:11AM	Enovis (ENOV) Q4 Earnings: What To Expect (StockStory)
Jan-29-25 07:00AM	Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th (GlobeNewswire)
Jan-17-25 06:00AM	Enovis Announces Leadership Change to International Surgical Business (GlobeNewswire)
Jan-08-25 10:36AM	Instacart Is Joining the S+P MidCap 400. Its Stock Is Rising. (Investopedia)
Jan-07-25 06:19PM	Maplebear Set to Join SandP MidCap 400; Enovis to Join SandP SmallCap 600 (PR Newswire)
06:19PM	Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600 (PR Newswire)
Jan-06-25 04:15PM	Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-18-24 04:10PM	Enovis to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 12:00PM	Enovis (ENOV) Upgraded to Buy: Here's Why (Zacks)
09:55AM	Wall Street Analysts Predict a 38.95% Upside in Enovis (ENOV): Here's What You Should Know (Zacks)
Nov-07-24 02:10AM	Enovis Corp (ENOV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:58AM	Q3 2024 Enovis Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-06-24 07:15AM	Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates (Zacks) +8.29%
06:17AM	Enovis: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Enovis Announces Third Quarter 2024 Results (GlobeNewswire)
Oct-31-24 12:02PM	Enovis (ENOV) Underperformed Amid Investors Disappointment (Insider Monkey)
04:32AM	Is Enovis Corporation (ENOV) The Best Industrial Stock to Buy According to Analysts? (Insider Monkey)
Oct-10-24 07:00AM	Enovis to Host Third Quarter 2024 Results Conference Call on November 6th (GlobeNewswire)
Oct-03-24 03:39PM	Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says (Benzinga)
Sep-09-24 03:50PM	Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies (GlobeNewswire)
Sep-05-24 08:00AM	Enovis Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting (GlobeNewswire)
05:29AM	Heres Why Enovis Corporation (ENOV) Slipped in Q2 (Insider Monkey)
Aug-20-24 11:54AM	Enovis (ENOV) Introduces STAR Ankle With e+ Polyethylene (Zacks)
08:00AM	Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR Cones to EMPOWR Revision Knee , Creating a Comprehensive Portfolio for Efficient Revision Procedures (GlobeNewswire)
05:52AM	Enovis launches enhanced STAR Ankle with new e+ Polyethylene (Medical Device Network)
Aug-19-24 08:00AM	Enovis Introduces STAR Ankle, now with e+ Polyethylene for Unmatched Durability (GlobeNewswire)
Aug-12-24 04:10PM	Enovis to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:12AM	Enovis Corporation (ENOV) Fell Due to Slower Than Expected Growth (Insider Monkey)
Aug-08-24 05:11AM	Q2 2024 Enovis Corp Earnings Call (Thomson Reuters StreetEvents) +7.37%
Aug-07-24 07:15AM	Enovis (ENOV) Q2 Earnings Top Estimates (Zacks)
06:13AM	Enovis: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Enovis Announces Second Quarter 2024 Results (GlobeNewswire)
Jul-31-24 10:01AM	Analysts Estimate Enovis (ENOV) to Report a Decline in Earnings: What to Look Out for (Zacks)
01:49AM	Does Enovis Corporation (ENOV) Face Short-Term Headwinds? (Insider Monkey)
Jul-25-24 06:00AM	Enovis Announces Time Change for Second Quarter 2024 Results Conference Call (GlobeNewswire)
Jul-16-24 07:00AM	Enovis to Host Second Quarter 2024 Results Conference Call on August 7th (GlobeNewswire)
Jul-15-24 10:24AM	Enovis' (ENOV) New System to Aid Reverse Shoulder Prosthesis (Zacks)
04:12AM	Enovis introduces AltiVate Reverse Glenoid System for arthroplasty (Medical Device Network)
Jul-12-24 08:00AM	Enovis Releases AltiVate Reverse Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse (GlobeNewswire)
02:14AM	Is Enovis Corporation (ENOV) Facing Stiff Competition? (Insider Monkey)
May-15-24 02:01PM	Alan Fournier's Strategic Moves in Q1 2024 Highlighted by Major Stake in Enovis Corp (GuruFocus.com)

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McDonald Damien	Chief Executive Officer	Sep 11 '25	Buy	30.97	6,457	199,973	102,753	Sep 11 05:59 PM
Tandy Bradley J	SVP and Chief Legal Officer	Aug 22 '25	Buy	31.41	3,200	100,512	43,515	Aug 25 06:30 AM
BERRY PHILLIP BENJAMIN (BEN)	SVP, Chief Financial Officer	Aug 20 '25	Buy	29.71	2,500	74,275	116,729	Aug 20 05:00 PM
PRYOR DANIEL A	EVP, Strategy & Business Dev.	Aug 13 '25	Buy	28.90	10,000	289,000	161,115	Aug 14 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ENOV

Enovis Corp

Upgrade your FINVIZ experience